Search - tctmd.com

Displaying 41 - 60 of 260

Sort: Relevancy | Date

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Daily News

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Michael O'Riordan

June 20, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News NY Valves 2024

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Michael O'Riordan

June 11, 2024

Presentation NY Valves 2024

Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve

Presenter: Joao L. Cavalcante

June 07, 2024

Presentation NY Valves 2024

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Presenter: Philipp Lurz

June 07, 2024

Presentation NY Valves 2024

Halt is Not Relevant

Presenter: Stephan Windecker

June 06, 2024

Presentation NY Valves 2024

Halt is Relevant

Presenter: Raj Makkar

June 06, 2024

Presentation NY Valves 2024

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Presenter: David A. Wood

June 06, 2024

Presentation NY Valves 2024

Debate Con

Presenter: Amr E. Abbas

June 06, 2024

Presentation NY Valves 2024

Debate Pro

Presenter: Howard C. Herrmann

June 06, 2024

News Conference News NY Valves 2024

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Michael O'Riordan

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

Presenter: Annette Maznyczka

June 06, 2024

Presentation NY Valves 2024

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Presenter: Anita W. Asgar

June 06, 2024

Presentation NY Valves 2024

Invasive Exercise Hemodynamics in Aortic Stenosis

Presenter: Abdullah Al-Abcha

June 06, 2024

News Conference News NY Valves 2024

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Michael O'Riordan

June 05, 2024

Presentation NY Valves 2024

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Presenter: Anjali Sharma

June 05, 2024

Presentation NY Valves 2024

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Presenter: Amar Krishnaswamy

June 05, 2024

Advertisement

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

The Hole Story: Interatrial Shunt Companies Are—Mostly—Pushing Ahead

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Good 3-Year Outcomes With Aortic Valve-in-Valve Replacement for Failed SAVR

Biomimetic Design Restores Flow and Hemodynamics and Leads to Significant LV Mass Regression: Update From the First-In-Human (FIH) Study With the Novel DurAVR Transcatheter Heart Valve

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Halt is Not Relevant

Halt is Relevant

Debate Con: Echo First and Only to Diagnose Bioprosthetic Valve Dysfunction /Failure

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Debate Con

Debate Pro

Risk Score IDs Patients Safe for Same-Day Discharge After Low-Risk TAVI

Keynote Lecture: Impact of TTVR on Hemodynamics and Ventricular Performance: Are New Generation Technologies Addressing the Physiologic Needs?

Asymmetric Expansion of Balloon Expandable Transcatheter Aortic Valve Prostheses: Implications for Valve Hemodynamics and Clinical Outcomes

DurAVR: Impact of Biomimetic Design on Restoration of Hemodynamics in Early ViV Experience

Invasive Exercise Hemodynamics in Aortic Stenosis

Reassuring 5-Year Outcomes for Sapien-Treated TAVI Patients With Small Annuli

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Defining Technical Success Post-M-TEER: MR Reduction and Hemodynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content